Amniotic Membrane Market

The global amniotic membrane market size was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030. Amniotic membrane (AM) or amnion is a thin membrane on the inner side of the fetal placenta. It completely surrounds the embryo and delimits the amniotic cavity, which is filled by amniotic liquid. In addition, amniotic membrane can be used as a dressing to ease ocular surface reconstruction and enable faster recovery from ailments. Amniotic membrane has gained the interest of healthcare providers and doctors, due to several benefits such as restoring the epidermal function and integrating itself into the process of healing, in addition to being a skin substitute in wound care. Amniotic membrane is utilized as a graft or patch in the treatment of eye diseases, depending upon the indication.

Amniotic membrane is expected to exhibit significant market growth during the forecast period, owing to growth in technological innovations to develop cost-effective therapies. Rise in amniotic membrane transplantation, rise in awareness and education about the benefits of amniotic membrane transplantation, and growth of geriatric population propel the market growth. However, the lack of healthcare professionals is expected to restrain the amniotic membrane market growth. Conversely, huge market potential in developing regions is expected to offer opportunities for market growth during the forecast period.

Impact Of Covid-19 On Amniotic Membrane Market (Pre And Post Analysis)

Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.

After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. In addition, only a few vaccines received emergency approvals for the COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries globally adopted nationwide lockdowns.

The overall impact of COVID-19 remains negative on the amniotic membrane market, Due to nationwide lockdowns, denied wound care services, and canceled or postponed elective surgeries. Elective surgeries were being denied (canceled/postponed) to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) towards COVID-19 patient care. In addition, various countries enforced lockdowns and curfews to curb the rise in number of COVID-19 cases. Due to these lockdowns, patients were not able to visit hospitals, OPDs, or clinics. This temporary denial of non-emergent healthcare services is expected to limit the growth of the amniotic products market. However, the demand for amniotic membrane products is expected to rise in the coming years.

The amniotic membrane market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of application, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review by Product

By product type, the amniotic membrane market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. The cryopreserved amniotic membrane segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, due to its high effectiveness and adoption rates, globally. This kind of membrane is usually stored in a cell culture medium that contains 50% glycerol at a temperature of -80°C. The amniotic membrane is well-preserved in cryopreserved amniotic membranes with its histological and biological properties. Thus, cryopreserved membranes are majorly used in visual surgeries that aid in reduced eye inflammation and enhanced recovery. Hence, this segment is anticipated to grow at a lucrative growth rate during the forecast period. On the other side, the demand for lyophilised amniotic membrane is projected to exhibit the fastest market growth during the forecast period, owing to placement of this membrane has not been associated with any significant adverse reactions or unexpected long-term effects.

Segment Review by Application

By applications, the amniotic membrane market is classified as surgical wounds, ophthalmology, and others. The surgical wound segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, as the membrane provides anti-inflammatory scarring effect, which minimizes the buildup of scar tissue.

Segment Review by End User

By end user, the hospitals segment presently dominates the market, and is expected to remain dominant during the forecast period, owing to increase in number of amniotic membrane transplantations performed at hospitals. Growing government initiatives to improve the healthcare infrastructure and expansion of middle-class population in developing nations, such as India result in increase in demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.

Segment Review by Region

By region, the amniotic membrane market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period owing to the well-established healthcare system and increase in adoption of amniotic membrane for varied applications. In addition to significant infrastructure for developmental research, availability of substantial research funds and growing government initiatives towards amniotic membrane transplantation are anticipated to drive the market growth.

This report provides comprehensive competitive analysis and profiles of prominent market players, such as Allosure, Inc, Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc, Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc., Skye Biologics Inc., and TissueTech, Inc.

Key benefits for stakeholders

• The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the amniotic membrane market growth is provided.
• A detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing amniotic membrane market opportunities.
• Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally.
• Key players and their strategies are provided to understand the competitive outlook of the amniotic membrane market.

 Amniotic Membrane Market Report Highlights